Post-HSCT graft failure due to refractory human cytomegalovirus successfully treated with haploidentical donor-derived immunoglobulins and stem cell graft infusion: A case report. (2021)
Attributed to:
Persistent Infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.antiviral.2021.105024
PubMed Identifier: 33577809
Publication URI: http://europepmc.org/abstract/MED/33577809
Type: Journal Article/Review
Volume: 188
Parent Publication: Antiviral research
ISSN: 0166-3542